Showing results (201-210 of 442) with videos related to
Sort By:
Pageof 45
Gastroenterology|December 3, 2014
Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysisGlen S Hazlewood, Ali Rezaie, Meredith Borman, et al.Science Advances|June 18, 2020
Human interleukin-4-treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse modelTimothy S Jayme, Gabriella Leung, Arthur Wang, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on BiologicsKenneth Ernest-Suarez, Luis E Murguía-Favela, Cora Constantinescu, et al.Journal of Leukocyte Biology|June 29, 2026
High-dimensional single-cell mass cytometry analysis of IL-4 treated human macrophages reveals heterogeneity and a CD206high anticolitic subsetBlanca E Callejas, Jared Schlechte, James A Sousa, et al.Scientific Reports|January 19, 2021
Dietary patterns, food groups and nutrients in Crohn's disease: associations with gut and systemic inflammationS Ali Naqvi, Lorian M Taylor, Remo Panaccione, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|October 8, 2024
Calcitonin gene-related peptide promotes epithelial reparative and anticolitic functions of IL-4 educated human macrophagesBlanca E Callejas, James A Sousa, Kyle L Flannigan, et al.Gastroenterology|January 24, 2007
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.Journal of Crohn'S & Colitis|January 11, 2015
Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel diseaseYvette P Y Leung, Gilaad G Kaplan, Stephanie Coward, et al.Alimentary Pharmacology & Therapeutics|May 24, 2019
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel diseaseChristopher Ma, Jeffrey K Lee, Anish R Mitra, et al.Journal of Crohn'S & Colitis|July 20, 2024
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY TrialChristopher Ma, Brian G Feagan, Zhongya Wang, et al.Pageof 45